EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Medication-related osteonecrosis of the jaw induced by a CDK 4/6 inhibitor (Palbociclib) in a patient who was naïve to antiresorptive bone therapy: a case report

Elodie Pallois, Nathalie Pham Dang, Eva Chenu, Laurent Devoize

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2025

DOI: 10.1016/j.oooo.2025.07.014 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2025. Verfasst von Elodie Pallois und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Chirurgie Maxillo-Faciale, CHU Clermont-Ferrand, Clermont-Ferrand, France; Service d'Odontologie, CHU Clermont-Ferrand, Clermont-Ferrand, …. Hauptthemen laut MEDLINE: Pyridines, Piperazines, Protein Kinase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHU Clermont-Ferrand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridinesPiperazinesProtein Kinase InhibitorsAntineoplastic AgentsHumansFemaleAged, 80 and overBreast NeoplasmsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Osteonecrosis

Substanzen

PyridinesPiperazinespalbociclibProtein Kinase InhibitorsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Antineoplastic Agents

Autor:innen und Institutionen

  • Service de Chirurgie Maxillo-Faciale, CHU Clermont-Ferrand, Clermont-Ferrand, France; Service d'Odontologie, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Service de Chirurgie Maxillo-Faciale, CHU Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, INSERM, Neuro-Dol, Clermont-Ferrand, France.
  • Service d'Anatomo-Pathologie et Cytologie, CHU Clermont-Ferrand, France.
  • Service d'Odontologie, CHU Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, INSERM, Neuro-Dol, Clermont-Ferrand, France. Electronic address: laurent.devoize@uca.fr.

Förderung

  • CHU Clermont-Ferrand

Zitieren

APA

Pallois, E., Pham Dang, N., Chenu, E., & Devoize, L. (2025). Medication-related osteonecrosis of the jaw induced by a CDK 4/6 inhibitor (Palbociclib) in a patient who was naïve to antiresorptive bone therapy: a case report. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2025.07.014

Vancouver

Pallois E, Pham Dang N, Chenu E, Devoize L. Medication-related osteonecrosis of the jaw induced by a CDK 4/6 inhibitor (Palbociclib) in a patient who was naïve to antiresorptive bone therapy: a case report. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2025. doi:10.1016/j.oooo.2025.07.014

BibTeX
@article{Pallois2025,
  author = {Pallois, Elodie and Pham Dang, Nathalie and Chenu, Eva and Devoize, Laurent},
  title = {Medication-related osteonecrosis of the jaw induced by a CDK 4/6 inhibitor (Palbociclib) in a patient who was naïve to antiresorptive bone therapy: a case report},
  journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
  year = {2025},
  doi = {10.1016/j.oooo.2025.07.014}
}
Kostenlos starten →